Oppenheimer Upgrades OvaScience To Outperform

Analysts at Oppenheimer upgraded

from Market Perform to Outperform, according to Bloomberg. The price target for OvaScience is set to $55. OvaScience shares have surged 344.19% over the past 52 weeks, while the S&P 500 index has gained 13.04% in the same period. OvaScience's shares rose 1.83% to $41.25 in pre-market trading.